Imaging for better decisions

Bioxydyn is a specialist imaging CRO that provides advanced MRI services for the pharmaceutical, academic, and medical devices sectors.

Liver Imaging

Oncology

Neuroimaging

Inflammation

Liver Imaging

Respiratory

Neuroimaging

Imaging for better decisions

Oncology

Inflammation

Bioxydyn is a specialist imaging CRO that provides advanced MRI services for the pharmaceutical, academic, and medical devices sectors.

We support all stages of the deployment of MRI in clinical trials, specialising in quantitative MRI biomarkers that provide safe and non-invasive insight into disease progression and drug response. We generate robust pharmacodynamic measurements of tissue and organ function across a wide range of disease areas. Our validated biomarkers deliver repeatable, high-quality data, enabling rich, specific insights from smaller patient populations.

With decades of experience and operational excellence, we deliver rigorous and efficient studies backed by industry-leading expertise.

Delivering your imaging study

From study design to database lock, Bioxydyn offers one integrated solution.

Study design

We design endpoints, documentation & MR protocols aligned to your objectives.

Site setup

We harmonise scanners, train site teams quickly and qualify your sites.

Transfer & QC

Sites upload data using our platform VoxelFlow. We monitor uploads and QC fast.

Analysis

We run validated analysis pipelines with full auditability.

Reporting

We deliver decision-ready outputs in your preferred data format. We archive documentation and data.

Respiratory function imaging

Bioxydyn offers imaging biomarkers for respiratory diseases such as cystic fibrosis, asthma, pulmonary hypertension, interstitial disease and COPD. We have extensive expertise in quantitative MRI methods for assessing regional lung function, including measurements of ventilation and perfusion.

Cancer imaging

Bioxydyn provides advanced functional MRI biomarkers in oncology, using techniques such as diffusion MRI and dynamic contrast-enhanced (DCE) MRI, and is the leading CRO offering tumor hypoxia imaging to inform therapy effectiveness or characterise tumour physiology.

Inflammation

Bioxydyn has delivered multiple studies for pharmaceutical companies using quantitative imaging of inflammation in a wide range of diseases, including functional imaging of joints in rheumatoid arthritis and osteoarthritis and renal imaging in nephritis.

Neuroimaging

Bioxydyn is experienced in the deployment of quantitative MRI methods for neuroscience in conditions including multiple sclerosis, neurodevelopmental conditions, dementia and neuro-oncology. Our collaboration with Queen Square Analytics enables advanced AI methods for patient stratification with a focus on multiple sclerosis and Alzheimer's disease.

Liver imaging

Bioxydyn offers MRI measurement of liver transporter fluxes using dynamic contrast-enhanced MRI (DCE-MRI), plus other imaging biomarkers, including relaxation time measurements, in the investigation of liver diseases.

Imaging Biomarkers in Drug Safety Assessment

Most successful drug developments involve a careful balance between safety and efficacy. Imaging biomarkers of drug safety have played a major role in avoiding drug-induced harm to many important organ systems, including liver, lung, brain, heart, and the musculoskeletal system.

Delivering your imaging study

From study design to database lock, Bioxydyn offers one integrated solution.

We design endpoints, documentation & MR protocols aligned to your objectives.

We harmonise scanners, train site teams quickly and qualify your sites.

Sites upload data using our platform VoxelFlow. We monitor uploads and QC fast.

We run validated analysis pipelines with full auditability.

We deliver decision-ready outputs with transparent documentation.

Imaging for better decisions

Imaging for better decisions